Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Novo Nordisk receives FDA nod for haemophilia A drug Esperoct

pharmaceutical-technologyFebruary 22, 2019

Tag: Novo Nordisk , FDA , haemophilia , Esperoct

PharmaSources Customer Service